Skip to main content

Advertisement

Table 4 Comparison of the AUROC values between the inflammation-based index and grade

From: A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization

period AUC(95%CI) P value
overall
 dNLR 0.649(0.603–0.694) < 0.001
 PNI 0.571(0.525–0.618) 0.003
 dNLR-PNI 0.685(0.633–0.724) < 0.001
 BCLC 0.659(0.611–0.702) < 0.001
1-year
 dNLR 0.637(0.597–0.676) < 0.001
 PNI 0.579(0.539–0.62) < 0.001
 dNLR-PNI 0.695(0.646–0.724) < 0.001
 BCLC 0.739(0.684–0.761) < 0.001
3-year
 dNLR 0.634(.590–0.677) < 0.001
 PNI 0.574(0.530–0.618) 0.001
 dNLR-PNI 0.679(0.635–0.720) < 0.001
 BCLC 0.652(0.609–0.684) < 0.001
5-year
 dNLR 0.645(0.600–0.691) < 0.001
 PNI 0.572(0.525–0.618) 0.003
 dNLR-PNI 0.683(0.639–0.737) < 0.001
 BCLC 0.594(0.542–0.648) < 0.001
  1. dNLR derived neutrophil-to-lymphocyte ratio, PNI prognostic nutritional index, BCLC barcelona clinic liver cancer